Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04662541 · ClinicalTrials.gov registry record · NA
Mobile Integrated Health in Heart Failure
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 2,005
- Enrollment target
NCT04662541: Completed NA study, sponsored by Columbia University.
NCT04662541 is a NA study that has completed, run by Columbia University. The registered enrollment target is 2,005 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04662541, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,005 participants
- Enrollment target
Study Summary
The purpose of this study is to compare how two different types of care after a hospitalization reduce hospital readmissions and symptom burden. The two types of care are a Transitions of Care Coordinator and Mobile Integrated Health. In the Transitions of Care Coordinator group, participants will receive a phone call from a care coordinator right after they go home following a hospitalization to check in. In the Mobile Integrated Health group, participants will be offered access to a community paramedic in case they need medical care while they are recovering at home after a hospitalization. The community paramedic will come to their home to perform an evaluation and set up a visit with an emergency physician via video conference. They may receive treatment at home or be transported to the emergency department. The investigators will be compare how well a Transitions of Care Coordinator and Mobile Integrated Health reduce readmissions to the hospital within 30 days of discharge and improve patient-reported health-related quality of life. The investigators hypothesize that participants in the Mobile Integrated Health group will have fewer readmissions to the hospital within 30 days of discharge and better health-related quality of life compared to participants in the Transitions of Care Coordinator group.
Primary Outcome
Number of readmissions to the hospital for any reason following a hospitalization
Interventions
- OTHER Mobile Integrated Health (MIH)
- OTHER Transitions of care coordinator (TOCC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,005 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
What the finished NCT04662541 record still lists
NCT04662541 is an interventional study that assigns participants to a tested intervention. Its 2,005 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher).
The record links to 0 conditions, and to 2 interventions - of which Mobile Integrated Health (MIH) is the first listed.
NCT04662541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04662541 about?
NCT04662541 is a clinical study titled "Mobile Integrated Health in Heart Failure". The purpose of this study is to compare how two different types of care after a hospitalization reduce hospital readmissions and symptom burden. The two types of care are a Transitions of Care Coordinator and Mobile Integrated Health. In the Transitions of Care Coordinator group, participants will r...
What is the current status of trial NCT04662541?
This trial is currently completed. It is a NA study. The enrollment target is 2,005 participants. The study started on 2021-01-04. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT04662541?
The interventions under investigation include: Mobile Integrated Health (MIH) (OTHER), Transitions of care coordinator (TOCC) (OTHER).
Who is sponsoring clinical trial NCT04662541?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04662541's enrollment target sits among peer trials
2,005 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI